Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 11 | |
Outperform | 17 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CNY
The 24 analysts offering 12 month price targets for Innovent Biologics Inc have a median target of 57.85, with a high estimate of 67.62 and a low estimate of 32.02. The median estimate represents a 50.25% increase from the last price of 38.50.
High | 75.6% | 67.62 |
Med | 50.2% | 57.85 |
Low | -16.8% | 32.02 |
Earnings history & estimates in CNY
Average growth rate | -1.65% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +80.24% |
More ▼